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138 Urinary inﬂammatory markers in the assessment of clinical
status in adults with CF
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Introduction: Sputum and blood inﬂammatory markers, including MMP-9, TNF-
alpha and IL-8, are elevated in CF and these same biomarkers increase during
pulmonary exacerbations. In this prospective study, we examine whether urinary
inﬂammatory biomarkers are detectable and reﬂect clinical status in CF adults.
Methods: Subjects were recruited at our regional centre, data included: demo-
graphics, spirometry and clinical status (‘stable’ or ‘exacerbation’). Subjects were
chronically infected with P. aeruginosa. Pulmonary exacerbations were deﬁned
according to the Fuchs criteria. Urinary MMP-9, TIMP-1, TIMP-2, neutrophil
elastase, alpha-1-antitrypsin and neutrophil gelatinase-associated lipocalin (NGAL)
were measured.
Results: 14 subjects (8 male) had provided 24 urine samples at the time of abstract
submission, FEV1% predicted (mean±SD) 49±14.2%. A1AT was signiﬁcantly
higher in ‘stable’ compared to ‘exacerbation’ samples [535.0 (210.1–653.1) ng/ml
vs. 86.0 (32.5–185.3) ng/ml, p< 0.006]. TIMP-2/A1AT ratio [0.0095 (0.0055–
0.019) vs. 0.046 (0.022–0.115), p = 0.013], TIMP-1/A1AT ratio [0.002 (0.002–
0.003) vs. 0.01 (0.002–0.04), p = 0.03] and NGAL/A1AT ratio [0.129 (0.01−0.3)
vs. 0.535 (0.23–1.07), p = 0.04] were signiﬁcantly lower in ‘stable’ compared to
‘exacerbation’ samples. All other inﬂammatory markers tested were detected, but
no signiﬁcant differences were seen in this preliminary analysis.
Conclusions:We demonstrate for the ﬁrst time that relevant inﬂammatory biomark-
ers are present in the urine of CF adults. The assessment of urinary inﬂammatory
markers may prove to be a useful non-invasive method to diagnose pulmonary
exacerbations, as well as to assess treatment response.
139 Gamma delta IL-6, IL-12 correlate with FEV1 in children with
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Objectives: To determine the expression of gamma delta IL-6 and IL-12 in children
with CF and controls. Furthermore to evaluate the relationship between gamma delta
IL-6 and IL-12 and lung function.
Material and Methods: Twenty children with CF (Age 6−14 yrs), in a stable
clinical condition were enrolled from the Outpatient Clinic of Department of
Pediatrics, PGIMER, Chandigarh, India. Ten healthy controls were also enrolled.
Sputum induction and processing were carried out according to standard guidelines.
Cell acquisition and analysis following antibody staining with anti human gamma
delta (PE labeled), IL-6, IL-12 (FITC labeled) was carried out ﬂowcytometrically
on FACS Calibur, using FACS CaliburTM software. Percentage positive cytokines
were reported as mean±SD. Spirometry was performed according to standard ATS/
ERS guidelines.
Results: We observed a high percentage of gamma delta IL-6 in children with
CF (17.9±2.8) as compared to controls (8.2±2.1) p< 0.05, gamma delta IL-12 in
children with CF (21.5±3.4) as compared to controls (10.4±2.5) p< 0.05. Gamma
delta IL-6 correlated negatively FEV1 (r = −0.582, P< 0.05). Furthermore gamma
delta IL-12 correlated negatively FEV1 (r = −0.742, P< 0.05).
Conclusion: Gamma delta T cells contribute to the dysregulated inﬂammatory
lung response in CF airways through increased production of IL-6 and IL-12.
Dysregulated gamma delta IL-6, IL-12 are associated with the clinical status in
children with CF. Increased expression of gamma delta IL-6 might contribute to
the enhanced IL-17 production in CF airways resulting in excessive neutrophilic
mediated lung tissue damage.
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Introduction and Aims: Chronic PA pulmonary infection is associated with
an increased host inﬂammatory response involving the release and activation of
damaging inﬂammatory mediators. Quantiﬁcation of these mediators may give an
indication of lung damage and changes in clinical status and mortality outcome.
The aim of this study was to determine whether serum IgG and IgA titre against
PA in clinically stable, chronically colonised adult CF patients (n = 40) correlates
with mortality and host inﬂammatory mediators.
Methods: Serum was assayed by ELISA for IgG and IgA against PA antigens.
Sputum HNE, Cathepsin S and Cathepsin B were measured by spectrophotometric
and ﬂuorogenic assays with sputum IL-8 and TNFa, plasma IL-6 and urine TNFr1
measured by ELISA. Correlations were calculated between inﬂammatory mediators
and antibody titre and results compared with a 10-year survival outcome.
Results: A signiﬁcant positive correlation was observed between IgG and IL-6
(p = 0.0005), TNFa (p = 0.0068), TNFr1 (p = 0.037), Cat S (p = 0.0106) and Cat B
(p = 0.0006). No correlation was found between IgG and IL-8 or HNE (p = 0.6229,
0.3921 respectively). In addition, IL-6 levels positively correlated with mortality
(p = 0.037). No correlations were found between IgA and any of the inﬂammatory
mediators.
Conclusion: Increases in IgG titre and IL-6 levels were shown to be associated
with 10 year mortality. Pro-inﬂammatory mediators correlated with IgG response,
and suggest that IgG to PA is an immunological marker of chronic infection and
survival.
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The TIM family of membrane receptors have emerged as potential therapeutic
targets to correct abnormal immune function in chronic inﬂammatory conditions.
TIM-3 serves as a functional receptor in bronchial epithelial cells and through
its natural ligand galectin-9 can modulate the inﬂammatory response. The aim of
this study was to investigate whether TIM-3 was expressed in neutrophils and what
function it may have in the healthy cell, which would be necessarily defective in the
adult cystic ﬁbrosis (CF) lung due to inactivation by neutrophil derived proteases.
TIM-3 membrane expression in circulating neutrophils was examined using RT-
PCR, western blotting and FACs analysis. Neutrophil degranulation was assessed
by western blotting and superoxide (O−2 ) production by cytochrome C reduction
assays.
Via signalling through TIM-3, galectin-9 induced neutrophil degranulation and O−2
production. We have demonstrated that TIM-3 expressed on neutrophils plays a
direct role in bacterial killing. Opsonisation of Pseudomonas aeruginosa with
galectin-9 (50 nM) enhanced neutrophil-mediated bacterial killing by 25%, an effect
abrogated by blockade of neutrophil TIM-3 receptors. This mechanism was gram-
negative bacteria speciﬁc and mediated via galectin-9/lipopolysaccharide binding.
In conclusion, our data suggest a novel role for TIM-3/galectin-9 in neutrophil
function with important consequences in neutrophil mediated killing of Pseu-
domonas. However, in the CF lung, membrane TIM-3 and its ligand galectin-9 are
proteolytically degraded, potentially contributing to the defective bacterial clearance
observed within the CF lung despite the high neutrophilic presence.
